Gray market peptides often contain far less drug than labeled and may carry toxins like arsenic, warns Catherine Varney, DO.
Catherine Varney, DO
Advertisement
Articles by Catherine Varney, DO
Gray market peptides cause vague symptoms patients may not disclose or link, so serious harms can go unnoticed until late, says Catherine Varney, DO.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
MASH Fibrosis, Not Resolution, Predicts Mortality: Zobair Younossi, MD
2
FDA Approves Once-Monthly Subcutaneous Olanzapine for Schizophrenia
3
NEI Director Highlights Pediatric Advances, AI’s Promise in Eye Care
4
5 Things to Know if Retatrutide Is Classified as a Biologic
5